FR3357M - Nouvelles applications thérapeutiques des p-aminobenzene-sulfonylamines dérivées de l'isoxazole notamment comme bactéricides. - Google Patents

Nouvelles applications thérapeutiques des p-aminobenzene-sulfonylamines dérivées de l'isoxazole notamment comme bactéricides.

Info

Publication number
FR3357M
FR3357M FR922534A FR922534A FR3357M FR 3357 M FR3357 M FR 3357M FR 922534 A FR922534 A FR 922534A FR 922534 A FR922534 A FR 922534A FR 3357 M FR3357 M FR 3357M
Authority
FR
France
Prior art keywords
sulfonylamines
aminobenzene
bactericides
isoxazole
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR922534A
Other languages
English (en)
Inventor
Hideo Kano
Masaru Ogata
Haruo Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of FR3357M publication Critical patent/FR3357M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C07D261/16—Benzene-sulfonamido isoxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR922534A 1962-08-21 1963-01-24 Nouvelles applications thérapeutiques des p-aminobenzene-sulfonylamines dérivées de l'isoxazole notamment comme bactéricides. Active FR3357M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3603062 1962-08-21

Publications (1)

Publication Number Publication Date
FR3357M true FR3357M (fr) 1965-06-08

Family

ID=12458301

Family Applications (2)

Application Number Title Priority Date Filing Date
FR922533A Expired FR1387009A (fr) 1962-08-21 1963-01-24 Procédés de préparation des p-amino benzènesulfonylamines dérivées de l'isoxazole
FR922534A Active FR3357M (fr) 1962-08-21 1963-01-24 Nouvelles applications thérapeutiques des p-aminobenzene-sulfonylamines dérivées de l'isoxazole notamment comme bactéricides.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR922533A Expired FR1387009A (fr) 1962-08-21 1963-01-24 Procédés de préparation des p-amino benzènesulfonylamines dérivées de l'isoxazole

Country Status (4)

Country Link
CH (1) CH431526A (fr)
DE (1) DE1263771B (fr)
FR (2) FR1387009A (fr)
GB (2) GB1002341A (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2888455A (en) * 1956-09-04 1959-05-26 Shionogi & Co New sulfonamide and process for producing the same

Also Published As

Publication number Publication date
CH431526A (de) 1967-03-15
GB1002342A (en) 1965-08-25
FR1387009A (fr) 1965-01-29
DE1263771B (de) 1968-03-21
GB1002341A (en) 1965-08-25

Similar Documents

Publication Publication Date Title
FR3290M (fr) Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.
FR1514M (fr) Nouvelles préparations thérapeutiques.
OA05587A (fr) Pulvérisateur portatif, notamment pour le traitement des cultures.
FR6247M (fr) Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
BE622943A (fr) Compositions thérapeutiques, contenant des dérivés d'émétine.
FR3357M (fr) Nouvelles applications thérapeutiques des p-aminobenzene-sulfonylamines dérivées de l'isoxazole notamment comme bactéricides.
DK121861B (da) Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.
FR2596M (fr) Nouvelles compositions thérapeutiques, en particulier pour le traitement de l'angine de poitrine.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR2692M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR1982M (fr) Nouvelles alcanamides-hydrazines n-substituées, utilisables notamment dans le traitement des infections staphylococciques rebelles.
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
FR2324M (fr) Nouvelles applications thérapeutiques des épithio-16, 17 stéroides.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR3419M (fr) Nouveaux médicaments notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR2759M (fr) Applications pharmacologiques des 16β-alkylthio-17β-hydroxy-estren-3-one comme substances hormonales artificielles.
FR1224M (fr) Traitement homéoflore des glandes sébacées.
FR2156M (fr) Nouvelles compositions thérapeutiques.
CH378479A (fr) Procédé d'ondulation permanente des cheveux
FR3864M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs.
FR1638M (fr) Composition pour le traitement des hémorroides, a base d'héparinate d'adrénalone.
DK111175B (da) Fremgangsmåde til fremstilling af 4',19-diacylcymaroler.
FR1011M (fr) Nouvelles bases de schiff dérivées des sulfanilamides.
FR1407M (fr) Nouveau médicament notamment pour le traitement des spasmes d'origine vasculaire.
FR2998M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.